Xueyang Li, Mengnan Liu, Yu Guo, Kaihui Zhang, Huaizhu Li, Qi Han, Shaoxiong Wang, Rungang Ma, Fengjiao Fan, Rula Sa, Tao Yun, Xuan Zhang, Qian Zhang, Xin Huang, Ran Liu, Guobang Li, Qianyi Zhang, Wei Hu, Guojun Wang
Accepted: 2026-03-17
Brucellosis, caused primarily by Brucella abortus, Brucella melitensis, and Brucella suis, remains a critical global public health challenge, particularly in regions where these pathogens persist in livestock and wildlife reservoirs. Despite decades of control measures-including vaccination, test-and-removal programs, and biosecurity protocols-persistent human and animal cases highlight the limitations of existing diagnostic and intervention strategies. CRISPR-based diagnostics have emerged as a transformative tool, offering rapid, ultrasensitive, and field-deployable pathogen detection. Here, we present BOVDS (Brucella melitensis/abortus/suis-other pathogens-vaccine detection and differentiation system), an innovative CRISPR/Cas13a-based platform that integrates ultrahigh sensitivity (10 copies/µL), screening for 10 major abortifacient pathogens, and precise strain differentiation-overcoming key challenges in Brucella diagnostics. By incorporating mismatched spacer designs, BOVDS achieves robust discrimination between B. melitensis, B. abortus, and B. suis despite their high genomic conservation. Additionally, the platform enables differentiation between vaccine and wild-type strains, addressing critical gaps in vaccination monitoring and epidemiological surveillance. Uniting laboratory-level accuracy with on-farm practicality, BOVDS facilitates real-time outbreak management, targeted culling, and environmental decontamination, advancing One Health initiatives toward sustainable brucellosis prevention and control. This system sets a new benchmark for next-generation zoonotic disease diagnostics, with broad applicability in global public and veterinary health.